ProbiusDx is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations.
ProbiusDx has raised $3.0M in total funding. The most recent round was Series B. The last funding was announced in May 2023.
ProbiusDx's investors include Cota Capital, Propel(X), Creative Destruction Lab (CDL), Stanford University, Heuristic Capital.
ProbiusDx is headquartered in El Cerrito, United States.
ProbiusDx is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations.
ProbiusDx is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProbiusDx — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/probiusdx. Accessed August 1, 2026.
VCBacked. (2023). ProbiusDx — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/probiusdx
{{cite web |title=ProbiusDx — Funding & Investors |url=https://www.vcbacked.co/company/probiusdx |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated